Found: 39
Select item for more details and to access through your institution.
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor–Positive Non‐Small Cell Lung Cancer.
- Published in:
- Cancer Reports, 2024, v. 7, n. 9, p. 1, doi. 10.1002/cnr2.70004
- By:
- Publication type:
- Article
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58327-w
- By:
- Publication type:
- Article
Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 25, p. 1831, doi. 10.1111/1759-7714.15403
- By:
- Publication type:
- Article
Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 21, p. 1665, doi. 10.1111/1759-7714.15382
- By:
- Publication type:
- Article
Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 6, p. 477, doi. 10.1111/1759-7714.15218
- By:
- Publication type:
- Article
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 35, p. 3475, doi. 10.1111/1759-7714.15140
- By:
- Publication type:
- Article
Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 331, doi. 10.3390/cancers14020331
- By:
- Publication type:
- Article
Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. e668, doi. 10.1634/theoncologist.2019-0593
- By:
- Publication type:
- Article
Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1210, doi. 10.1634/theoncologist.2017-0586
- By:
- Publication type:
- Article
Malignant lymphoma with diffuse cardiac involvement detected by multiple imaging examinations: a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 12, p. 1089, doi. 10.1111/1759-7714.14853
- By:
- Publication type:
- Article
Efficacy and safety of carboplatin and etoposide in older extensive‐stage small‐cell lung cancer patients with a poor performance status.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 9, p. 805, doi. 10.1111/1759-7714.14811
- By:
- Publication type:
- Article
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 5, p. 442, doi. 10.1111/1759-7714.14761
- By:
- Publication type:
- Article
Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 14, p. 2064, doi. 10.1111/1759-7714.14529
- By:
- Publication type:
- Article
Impact of losing adipose tissue on outcomes from PD‐1/PD‐L1 inhibitor monotherapy in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1496, doi. 10.1111/1759-7714.14421
- By:
- Publication type:
- Article
Dramatic, significant metabolic response to a one‐time pembrolizumab treatment following a relapse of pre‐existing organizing pneumonia in a patient with advanced non‐small cell lung cancer: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 22, p. 3076, doi. 10.1111/1759-7714.14185
- By:
- Publication type:
- Article
Zinc‐finger E‐box‐binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 10, p. 1536, doi. 10.1111/1759-7714.13937
- By:
- Publication type:
- Article
Impact of the generation of EGFR‐TKIs administered as prior therapy on the efficacy of osimertinib in patients with non‐small cell lung cancer harboring EGFR T790M mutation.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 3, p. 329, doi. 10.1111/1759-7714.13742
- By:
- Publication type:
- Article
Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with EGFR T790M mutation.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 1, p. 140, doi. 10.1111/1759-7714.13255
- By:
- Publication type:
- Article
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10133-1
- By:
- Publication type:
- Article
The efficacy and safety of anamorelin among patients with diabetes.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1115, doi. 10.1007/s10147-024-02546-8
- By:
- Publication type:
- Article
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 96, doi. 10.1007/s10147-023-02451-6
- By:
- Publication type:
- Article
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.
- Published in:
- 2015
- By:
- Publication type:
- journal article
CT Guided Needle Biopsy of Peripheral Lesions–Lesion Characteristics That May Increase the Diagnostic Yield and Reduce the Complication Rate.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 2031, doi. 10.3390/jcm10092031
- By:
- Publication type:
- Article
Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2902-0
- By:
- Publication type:
- Article
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 411, doi. 10.1007/s10637-021-01183-6
- By:
- Publication type:
- Article
Treatments and outcomes of advanced/ recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 12, p. 1135, doi. 10.1093/jjco/hyw124
- By:
- Publication type:
- Article
Phase II study of nab‐paclitaxel + carboplatin for patients with non‐small‐cell lung cancer and interstitial lung disease.
- Published in:
- Cancer Science, 2019, v. 110, n. 12, p. 3738, doi. 10.1111/cas.14217
- By:
- Publication type:
- Article
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
- Published in:
- Cancer Science, 2018, v. 109, n. 8, p. 2539, doi. 10.1111/cas.13692
- By:
- Publication type:
- Article
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 162, n. 2, p. 435, doi. 10.1007/s11060-023-04300-y
- By:
- Publication type:
- Article
Severe mediastinitis over a month after endobronchial ultrasound-guided transbronchial needle aspiration.
- Published in:
- Respirology Case Reports, 2019, v. 7, n. 5, p. 1, doi. 10.1002/rcr2.426
- By:
- Publication type:
- Article
Clinical impact of tumour burden on the efficacy of PD‐1/PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1451, doi. 10.1002/cam4.5035
- By:
- Publication type:
- Article
The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 668, doi. 10.1007/s10147-014-0761-8
- By:
- Publication type:
- Article
Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
- Published in:
- Lung, 2018, v. 196, n. 5, p. 531, doi. 10.1007/s00408-018-0134-6
- By:
- Publication type:
- Article
Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 3, p. 521, doi. 10.1007/s00280-014-2670-y
- By:
- Publication type:
- Article
Osimertinib for patients with EGFR T790M mutation-positive non–small-cell lung cancer and a poor performance status.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 7, p. 671, doi. 10.1093/jjco/hyz041
- By:
- Publication type:
- Article